An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
暂无分享,去创建一个
[1] A. Festa,et al. Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report , 2015, Experimental Hematology & Oncology.
[2] F. van Rhee,et al. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. , 2014, Blood.
[3] M. Kojima,et al. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012 , 2013, Journal of clinical and experimental hematopathology : JCEH.
[4] P. Kvale,et al. Castleman's disease. , 1995, Mayo Clinic proceedings.
[5] B. Castleman,et al. Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.